These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 820188)

  • 41. A cost--benefit analysis for a multimodality heroin treatment project.
    Sirotnik KA; Bailey RC
    Int J Addict; 1975; 10(3):443-51. PubMed ID: 809366
    [No Abstract]   [Full Text] [Related]  

  • 42. Agency differences in posttreatment outcomes: a follow-up of drug abuse treatment clients.
    Joe GW; Singh BK; Lehman W; Simpson DD; Sells SB
    Int J Addict; 1983 May; 18(4):523-38. PubMed ID: 6629561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug abuse treatment readmissions and outcomes. Three-year follow-up of DARP patients.
    Simpson DD; Savage LJ
    Arch Gen Psychiatry; 1980 Aug; 37(8):896-901. PubMed ID: 7406653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The nature and status of drug abuse treatment.
    Nurco DN; Kinlock TW; Hanlon TE
    Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A model for drug abuse treatment program evaluation.
    Sheffet A; Hickey RF; Lavenhar MA; Wolfson EA; Duval H; Millman D; Louria DB
    Prev Med; 1973 Dec; 2(4):510-23. PubMed ID: 4778459
    [No Abstract]   [Full Text] [Related]  

  • 46. From maintenance to abstinence in a therapeutic community: clinical treatment methods.
    Sorensen JL; Acampora A; Iscoff D
    J Psychoactive Drugs; 1984; 16(3):229-39. PubMed ID: 6491838
    [No Abstract]   [Full Text] [Related]  

  • 47. Methadone programmes. The costs and benefits to society and the individual.
    Ralston GE; Wilson P
    Pharmacoeconomics; 1996 Oct; 10(4):321-6. PubMed ID: 10172793
    [No Abstract]   [Full Text] [Related]  

  • 48. The impact of methadone and drug-free treatment on criminal behavior.
    DeAngelis GG; McCaslin FC; Kaplan S; Ungerleider JT
    Drug Alcohol Depend; 1976 Oct; 1(6):399-413. PubMed ID: 1017385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding drug user treatment evaluation: some unresolved issues.
    Einstein S
    Int J Addict; 1981 Apr; 16(3):381-400. PubMed ID: 7275391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Client well-being in drug treatment: a social ecological analysis.
    Ruffing-Rahal MA
    Int J Addict; 1985 Sep; 20(9):1305-20. PubMed ID: 4077327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methadone in Miami.
    Hoogerbeets J
    Int J Addict; 1970 Sep; 5(3):499-506. PubMed ID: 5524384
    [No Abstract]   [Full Text] [Related]  

  • 52. The evaluation of a consultation service for delivery of substance abuse services in a hospital setting.
    Barker SB; Knisely JS; Dawson KS
    J Addict Dis; 1999; 18(1):73-82. PubMed ID: 10234564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The costly bonus: cocaine related crime among methadone treatment clients.
    Hunt D; Spunt B; Lipton D; Goldsmith D; Strug D
    Adv Alcohol Subst Abuse; 1986; 6(2):107-22. PubMed ID: 3604786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phoenix House: an interview with Mitchell S. Rosenthal.
    Sharaf MR
    Semin Psychiatry; 1971 Feb; 3(1):226-44. PubMed ID: 5173040
    [No Abstract]   [Full Text] [Related]  

  • 55. The effects of methadone maintenance with opioid takers. A review and some findings from one British city.
    Paxton R; Mullin P; Beattie J
    Br J Psychiatry; 1978 May; 132():473-81. PubMed ID: 656711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retention in treatment of drug users: 1971-1972 DARP admissions.
    Joe GW; Simpson DD
    Am J Drug Alcohol Abuse; 1975; 2(1):63-71. PubMed ID: 1190195
    [No Abstract]   [Full Text] [Related]  

  • 57. A national follow-up study to evaluate the effectiveness of drug abuse treatment: a report on cohort 1 of the DARP five years later.
    Sells SB; Simpson DD; Joe GW; Demaree RG; Savage LJ; Lloyd MR
    Am J Drug Alcohol Abuse; 1976; 3(4):545-56. PubMed ID: 1032763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The treatment of dependence in the therapeutic community].
    Roussaux JP; Ledoux Y; Snoy T; Simonart C; Pelc I
    Acta Psychiatr Belg; 1990; 90(5-6):259-77. PubMed ID: 1670403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of mixed abusers in methadone maintenance: role of psychiatric factors.
    McLellan AT; Woody GE; Evans BD; O'Brien CP
    Ann N Y Acad Sci; 1982; 398():65-78. PubMed ID: 6961869
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment for drug abuse. Follow-up outcomes and length of time spent.
    Simpson DD
    Arch Gen Psychiatry; 1981 Aug; 38(8):875-80. PubMed ID: 7259424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.